1

1. Steinhoff, M., Buddenkotte, J. Rosasea. In: Kang, S., Amagai, M., Bruckner, A. L., Enk,
A. H.,Morgolis, D. J., McMichael, A. J. (2019). Fitzpatrick's Dermatology 9th Ed.
McGraw-Hill Education, 1419-47.
2. Del Rosso, J., Tanghetti, E., Webster, G., Gold, L. S., Thiboutot, D., Gallo, R. L.
(2019). Updateon the management of rosasea from the american acne & rosasea
society (AARS). J Clin Aesthet Dermatol, 12(6), 17–24.
3. Barakji, Y. A., Rønnstad, A. T. M., Christensen, M. O. (2022). Assessment of
Frequency of Rosasea Subtypes in Patients With Rosasea: A Systematic Review and
Meta-analysis. JAMA Dermatol. doi:10.1001/jamadermatol.2022.0526
4. Sitohang, I. B. S., Parrol, F., Fitri, E. M., Nora, R. D. (2021). Papulopustular and
Ocular Rosasea with an Alleged Coincidence of Cutaneous Lupus Erythematosus: A
Case Report. Case Rep Dermatol, 13(1), 62-8.
5. Danby, F. W. (2005). Rosasea, acne rosasea, and actinic telangiectasia. J Am Acad
Dermatol,52(3), 539-40.
6. Buddenkotte, J., Steinhoff, M. (2018). Recent advances in understanding and
managing rosasea. F1000Res. 7.
7. Sarkar, R., Podder, I., Jagadeesan, S. (2020). Rosasea in skin of color: A
comprehensive review. Indian J Dermatol Venereol Leprol, 86(6), 611-21.
8. Culp, B., Scheinfeld, N. (2009). Rosasea: A Review. PT, 34(1), 38-45. PMID:
19562004
9. Reiner, B. M., Kang, S., Chien, A. L. (2017). Rosasea: Epidemiologi, pathogenesis
and treatment. Dermatoendocrinol, 9(1), e1361574.
10. Dai, R., Lin, B., Zhang, X., Lou, Y., Xu, S. (2021). Depression and Anxiety in
Rosasea Patients: A Systematic Review and Meta-Analysis. Dermatol Ther (Heidelb),
11(6), 2089-105.
11. Trave, I., Micalizzi, C., Gasparini, G., Cozzani, E., & Parodi, A. (2021). Dermoscopy
of papulopustular rosasea and comparison of dermoscopic features in patients with
or without concomitant Demodex folliculorum. Clinical and Experimental
Dermatology. doi:10.1111/ced.14731.
12. Segal, E. (2010). Dermoscopy as a diagnostic tool in demodicidosis. Int. J. Dermatol,
49, 1018-23. PMID: 20931672.
13. Yun, C. H., Yun, J. H., Baek, J. O., Roh, J. Y., & Lee, J. R. (2017). DemodexMite
Density Determinations by Standardized Skin Surface Biopsy and Direct Microscopic

Universitas Indonesia
 2

Examination and Their Relations with Clinical Types and Distribution Patterns.
Annals of Dermatology, 29(2), 137. doi:10.5021/ad.2017.29.2.137.
14. Kubanov A, Gallyamova Y, Kravchenko A. (2019). Analysis of Methods of The
Demodex Mites Diagnosis. EMJ Dermatol, 7(1), 67-68.
15. Forton, F., Song, M. (1998). Limitations of standardized skin surface biopsy in
measurement of the density of Demodex folli-culorum. A case report. Br J Dermatol,
139, 697-700.
16. Alexander, H., Brown, S., Danby, S., & Flohr, C. (2018). Research Techniques Made
Simple: Transepidermal Water Loss Measurement as a Research Tool. Journal of
Investigative Dermatology, 138(11), 2295–2300.e1. doi:10.1016/j.jid.2018.09.001
17. Honari, G., & Maibach, H. (2014). Skin Structure and Function. Applied
Dermatotoxicology, 1–10. doi:10.1016/b978-0-12-420130-9.00001-3.
18. Akdeniz, M., Gabriel, S., Lichterfeld-Kottner, A., Blume-Peytavi, U., & Kottner, J.
(2018). Transepidermal water loss in healthy adults: a systematic review and meta-
analysis update. British Journal of Dermatology. doi:10.1111/bjd.17025.
19. Farahmand, S., Tien, L., Hui, X., & Maibach, H. I. (2009). Measuring transepidermal
water loss: a comparativein vivostudy of condenser-chamber, unventilated-chamber
and open-chamber systems. Skin Research and Technology, 15(4), 392–
398. doi:10.1111/j.1600-0846.2009.00376.x.
20. Flohr, C., England, K., Radulovic, S., McLean, W. H. I., Campbell, L. E., Barker, J.,
Lack, G. (2010). Filaggrin loss-of-function mutations are associated with early-onset
eczema, eczema severity and transepidermal water loss at 3 months of age. British
Journal of Dermatology, 163(6), 1333–1336. doi:10.1111/j.1365-2133.2010.10068.x.
21. Thiboutot, D., Anderson, R., Cook-Bolden, F., Draelos, Z., Gallo, R. L., Granstein, R.
D. (2020). Standard management options for rosasea: The 2019 update by the
National Rosasea Society Expert Committee. J Am Acad Dermatol, 82(6), 1501-10.
22. Li, G., Wang, B., Zhao, Z. (2020). Excessive cleansing: an underestimating risk factor
of rosasea in Chinese population. Arch Dermatol Res.
23. National Rosasea Society. (2020). FDA Approved Treatments For Rosasea.
https://www.rosasea.org/patients/management-options/fda-approved-rosasea-
treatments
24. Elewski, B. E., Flesicher, A. B., Pariser, D. M. (2003). A comparison of 15% azelaic
acid gel and 0.75% metronidzole gel in the topical treatment of papulopustular
rosasea: Results of a randomized trial. Arch Dermatol, 139(11), 1444–1450.
25. American Family Physician. (2009). Treatment Options for Acne Rosasea. Am Fam

Universitas Indonesia
 3

Physician, 80(5), 461-485

26. Colon, L. E., Johnson, L. A., Gottschalk, R. W. (2007). Cumulative irritation potential
among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%
Cutis, 79, 317–321.
27. van Zuuren, E. J., Graber, M. A, Hollis, S., Chaudhry, M., Gupta, A. K., Gover, M.
(2005). Interventions for rosasea Cochrane Database Syst Rev, (3), CD003262
28. Torok, H. M., Webster, G., Dunlap, F. E., Egan, N., Jarratt, M., Stewart, D. (2005).
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus
metronidazole 0.75% cream for rosasea. Cutis, 75(6), 357–363.
29. Nasir, M. A. (1985). Treatment of rosasea with tetracycline and metronidazole-a
comparative study. J Pak Med Assoc, 35(5), 148–149.
30. Rebora, A. (2002). The management of rosasea. Am J Clin Dermatol, 3, 489–496.
31. Rivero, A. L., Whitfeld, M. (2018). An update on the treatment of rosasea. Aust
Prescr, 41(1), 20-24.
32. Fernandez-Obregon, A., Patton, D. L. (2007). The role of Chlamydia pneumoniae in
the etiology of acne rosasea: Response to the use of oral azithromycin. Cutis, 79, 163–
167.
33. Bakar, O., Demircay, Z., Yuksel, M. (2007). The effect of azithromycin on reactive
oxygen species in rosasea. Clin Exp Dermatol, 32, 197–200.
34. Samuelson, J. (1999). Why Metronidazole Is Active against both Bacteria and
Parasites. Antinicrob Agents Chemother, 43(7), 1533-1541.
35. PubChem. Metronidazole.
https://pubchem.ncbi.nlm.nih.gov/compound/Metronidazole. Diakses pada tanggal 2
Juni 2022
36. McClellan, K. J., Noble, S. (2000). Topical Metronidazole: A Review of its Use in
Rosasea. Am J Clin Dermatol, 1(3), 191-199.
37. Aronson, I. K., Rumsfield, J. A., West, D. P. (1987). Evaluation of topical
metronidazole gel in acne rosasea. Drug Intell Clin Pharm, 21, 346-51.
38. Lamp, K. C., Freeman, C. D., Klutman, N. E. (1999). Pharmacokinetics and
pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet, 36 (5),
353-73.
39. Kacew, S. (1993). Adverse effects of drugs and chemicals in breast milk on the
nursing infant. J Clin Pharmacol, 33, 213-21.
40. Durbin, K. (2021). Metronidazole. https://www.drugs.com/metronidazole.html.
Diakses pada tanggal 2 Juni 2022.

v Universitas Indonesia
 4

41. Persi, A., Rebora, A. (1981). Metronidazole and Demodex folliculorum.

Acta Derm Venereol, 61, 182-3.
42. Schachter, D., Schachter, R. K., Long, B. (1991). Comparison of
metronidazole 1% cream versus oral tetracycline in patients with rosasea.
Drug Invest, 3 (4), 220-4.
43. Bitar, A., Bourgouin, J., Dore, N. (1990). A double-blind randomised study
of metronidazole (Flagyl®) 1% cream in the treatment of acne rosasea: a
placebo- controlled study. Drug Invest, 2(4), 242-8.
44. Dahl, M. V., Katz, H. I, Krueger, G. G. (1998). Topical metronidazole
maintains remissions of rosasea. Arch Dermatol, 134, 679-83.
45. Hawker, G. A., Mian, S., Kendzerska, T., French, M. (2011). Measures of adult
pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain
(NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain
Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36
Bodily Pain Scale SF. Arthritis Care Res, 63(11), 240–52.
46. Nelson, B. R., Fader, D. J., Gillard, M. (1995). Pilot histologic and ultrastructural
study of the effects of medium-depth chemical facial peels on dermal collagen in
patients with actinically damaged skin. J Am Acad Dermatol, 32, 472-8.
47. Bunyaratavej, S., Rujitharawanong, C., Kasemsam, P., Boonchal, W.,
Muanprasert, C., Matthapan, L., Leeyaphan, C. (2016). Skin scrapings versus
standardized skin surface biopsy to detect Demodex mites in patients with facial
erythema of uncertain cause-a comparative study. Indian Journal of Dematology,
Venereology, and Leprology, 82, 519-22.
48. Sari, I., Agusni, I., Mira, D. (2018). Comparison of Transepidermal Water
Loss Values in Anesthetic and Nonanesthetic Macule lesions in Leprosy
Patients. Periodical of Dermatology and Venereology, 30(3), 224-230.
49. C+K electronic. (2020). Tewameter® TM 300. https://www.courage-
khazaka.de/en/16-wissenschaftliche-produkte/alle-produkte/172-
tewameter-e. Diakses pada tanggal 13 Juni 2022.
50. Gardien, K. L. m., Baas, D. C., de Vet, H. C. W. (2016). Transepidermal
water loss measured wit the Tewameter TM300 in burn scars. BURNS, 42,
1455-1462.

v Universitas Indonesia